AGP Executive Report
Last update: 2 hours agoAdolescent Brain & Cannabis Research: A new Neuropsychopharmacology study links teen cannabis use—especially higher-potency products—to differences in dopamine-related brain systems tied to motivation and reward. Psychosis Risk Debate: Yale psychiatrist Deepak D’Souza weighs in on how cannabis exposure may raise psychosis risk in vulnerable people, with abstinence tied to better outcomes. Teen Risk-Taking Angle: A Nature Communications study suggests some teens may use substances like weed or alcohol to “get the system going” when dopamine reward biology is lower. Clinical Conversations Gap: Fewer than 1 in 5 older cannabis users report discussing use with clinicians, raising concerns for guidance and safety. Legal/Regulatory Watch: New Hampshire’s Gov. Kelly Ayotte vetoed a bill that would let medicinal dispensaries grow their own cannabis via on-site greenhouses. Industry/Business: Avicanna closed a non-brokered private placement to fund working capital and cannabinoid R&D. Retail Compliance: Ontario regulators ordered SNDL to divest de facto control of retail stores or face license action. Public Safety & Policy: Court rulings and ongoing state budget fights keep cannabis policy, enforcement, and public trust in the spotlight.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
